Biajoux et al.
Figure 4
A
B cells
Control
Inactive
100
100
Active
80
80
% of Max
Relative cell
% of number
Max
HEK
60
60
40
40
20
20
0
0
10
1
2
3
10
10
FL2-H: RDC1 PE
10
4
10
0
H = 20.01
P < 0.0001
***
***
***
H = 30.04
P < 0.0001
***
***
***
1
2
10
10
FL2-H: RDC1R&D PE
3
10
4
H = 11.20
P = 0.004
% of CXCR7+
CD19+ CD27- B cells
CXCR7 MFI
10
**
*
**
% of CXCR7+ CD19low
CD27high B cells
% of CXCR7+
CD19+ total B cells
% of CXCR7+
CD19+ CD27+ B cells
CD19
0
H = 11.95
P = 0.003
***
C
CXCR7+ B cells (%)
10
B
Sample
%
Untransduced
AP HP IP 120309.011 27.7
+ CXCR7
AP HP IP 060209.015 13.1
AP HP IP 150409.017 6.87
AP HP IP 060209.014 12.4
r = 0.102
P = 0.548
**
**